Susan Knox
Publication Details
-
Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Int J Radiat Oncol Biol Phys. 2004; (1): 197-203
Patients with glioblastoma multiforme (GBM) do extremely poorly despite aggressive therapy with surgery, radiotherapy (RT), and chemotherapy. In an effort to increase the efficacy of therapy for GBM, we studied the efficacy of arsenic trioxide (ATO) combined with high-dose RT in GBM cells in vitro and GBM xenograft tumors in nude mice.
Help
Trial Administration